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Abstract

The motion of amino acid residues on the millisecond (ms) time scale is involved in the tight regulation of
catalytic function in numerous enzyme systems. Using a combination of mutational, enzymological, and
relaxation-compensated 15N Carr−Purcell−Meiboom−Gill (CPMG) methods, we have previously established the
conformational significance of the distant His48 residue and the neighboring loop 1 in RNase A function. These
studies suggested that RNase A relies on an intricate network of hydrogen bonding interactions involved in
propagating functionally relevant, long-range ms motions to the catalytic site of the enzyme. To further
investigate the dynamic importance of this H-bonding network, this study focuses on the individual replacement
of Thr17 and Thr82 with alanine, effectively altering the key H-bonding interactions that connect loop 1 and
His48 to the rest of the protein. 15N CPMG dispersion studies, nuclear magnetic resonance (NMR) chemical shift
analysis, and NMR line shape analysis of point mutants T17A and T82A demonstrate that the evolutionarily
conserved single H-bond linking His48 to Thr82 is essential for propagating ms motions from His48 to the active
site of RNase A on the time scale of catalytic turnover, whereas the T17A mutation increases the off rate and
conformational exchange motions in loop 1. Accumulating evidence from our mutational studies indicates that
residues experiencing conformational exchange in RNase A can be grouped into two separate clusters displaying
distinct dynamical features, which appear to be independently affected by mutation. Overall, this study
illuminates how tightly controlled and finely tuned ms motions are in RNase A, suggesting that designed
modulation of protein motions may be possible.

Ribonuclease A (RNase A),1 like many enzymes, utilizes molecular motions during its conversion of substrate to
product (1). In RNase A, the rate-limiting step for its rapid cleavage of single-stranded RNA is the product release
step, which includes a conformational change in the enzyme itself (2, 3). These enzyme motions occur on the
millisecond (ms) time scale, as first elucidated from temperature jump experiments in the mid-1960s (2, 4-9).
These equilibrium perturbation experiments detected a pH-dependent motion in RNase A that occurred with a
frequency of 103 s−1. On the basis of the pH dependence and solvent isotope effects for this motion, in addition
to the measurement of its activation enthalpy, Hammes and co-workers predicted that a solvent-exchangeable
hydrogen atom associated with a histidine residue was integral to the observed motion in RNase A. Subsequent
nuclear magnetic resonance (NMR) studies implicated histidine 48 as the residue involved in this conformational
motion on the basis of the observed discontinuity of chemical shift changes during pH titrations (10-12). The
three-dimensional structure of RNase A showed that His48 was not located at the enzyme active site but rather
∼18 Å distant with its imidazole side chain partially sequestered from solvent and positioned in a region
primarily composed of residues from loop 1, which connects α-helix 1 with α-helix 2 (Scheme 1) (13). The
molecular details of how His48 is involved in the rate-limiting product release step (14) have largely gone
unresolved.
1 Abbreviations: 3′-CMP, cytidine 3′-monophosphate; ECP, eosinophil cationic protein; rcCPMG, relaxationcompensated Carr−Purcell−Meiboom−Gill; RNase A, ribonuclease A; RNase A-CO, codon-optimized ribonuclease
A; WT, wild-type RNase A.

Scheme 1. Hydrogen Bonding Interactions between His48 and Its Surrounding Environment in RNase Aa
Scheme a Hydrogen bonds are shown as dashed lines, and atoms are displayed according to a standard coloring
scheme: green for carbon, red for oxygen, and blue for nitrogen.
Advances in solution NMR techniques for characterizing ms time scale molecular motions (15) and the ability to
readily incorporate site specific changes at individual amino acid sites have allowed further investigation of the
role of motions in RNase A function. Initial NMR CPMG relaxation dispersion studies of uniformly 15N-labeled
apo-RNase A showed that multiple residues located throughout RNase A were involved in a ms conformational
exchange process and that the time scale of this motion closely matched the overall catalytic turnover rate (16).
These results suggested that motions in RNase A were more widespread than just the immediate area
surrounding His48. Given the numerous residues involved in this motion, it was not initially clear that His48 was
indeed the cause of the motions in RNase A. However, subsequent pH studies of this motion (unpublished
observations) did implicate a residue(s) with a pKa above 6.0 as being important for maintaining the observed
motions. The rate of these motions was also found to be dependent on the deuterium content of the water
solvent. This observed kinetic solvent isotope effect on protein motions (17), bolstered by additional proton
inventory measurements, suggested that a single exchangeable proton was the source of these ms motions (18).
Mutagenesis of His48 resulted in the loss of ms motions in the region surrounding His48, including loop 1, α1,
α2, β1, β2, and β4 (18). In addition, exchange of loop 1 in RNase A for the shorter loop found in the RNase A
homologue, eosinophil cationic protein (ECP), caused a similar loss of observable motions in the chimeric
enzyme in these same regions (19). Thus, the majority of evidence to date implies that His48 plays an essential
role in modulating the functional motions in RNase A.
Histidine 48 acts as a bridge that links loop 1 (residues 14−24), β-strand 1 on which His48 resides (residues
43−48), and β-strand 4 (residues 79−86) (Scheme 1). Both β1 and β4 comprise the B2 subsite of the enzyme’s
active site, forming the binding site for the pyrimidine portion of the single-stranded RNA (ssRNA) substrate. In
the apoenzyme, a collection of hydrogen bonds links the imidazole side chain of His48 loop 1 and the B2 subsite
(Scheme 1). The Nε2 group of His48 makes a H-bond with Oγ1 of Thr82. On the other side of the imidazole ring,
Nδ1 forms three interactions: one with Oγ1 of Thr17, and two with the carbonyl oxygens of Thr17 and Asp14. In
the 3′-CMP-bound product state, these interactions are maintained, although the distances are altered
commensurate with the ∼1 Å shift of loop 1, and an additional interaction between Nε2 of His48 and the side
chain of Gln101 is formed. These multiple interactions stand in some contrast to the linear NMR proton
inventory experiments that suggested a single important hydrogen bond was involved in the motion in RNase A
(18). However, analysis of 266 RNase A sequences revealed that His48 is 86% conserved (20). Moreover, when
His48 is present, a threonine also is found at position 82. In contrast, Thr17 is only 17% conserved among these
ribonucleases, suggesting that the coexistence of the His48−Thr82 pair is a more stringent requirement for

function. To further investigate the importance of the hydrogen bonding network involving His48, we
individually mutated Thr82 and Thr17 to alanine and studied the ms motions and product analogue binding in
comparison to those of wild-type RNase A (WT). Our results show that the single His48 (Nε2)−Thr82 (Oγ1) H-bond
is mandatory for the propagation of WT ms dynamics and uncouples loop 1 dynamics from the remainder of the
protein in mutant T82A. In contrast, while still considerably destructive, removal of the single Nδ1−Oγ1 H-bond
linking Thr17 to His48 allows for the partial conservation of ms dynamics in variant T17A. This mutational
disruption of enzyme motion offers new insights pertaining to the importance of H-bonding interactions in the
propagation of functional motions in proteins, opening the door to the potential allosteric modulation of
enzyme activity by mutagenesis.

Materials and Methods
DNA Constructs
Oligonucleotide synthesis and DNA sequencing were performed by the W. M. Keck Foundation Biotechnology
Resource Laboratory (Yale University), and the wild-type, 372 bp bovine RNase A gene was codon-optimized
(RNaseA-CO) by GenScript (Piscataway, NJ) for enhanced expression in Escherichia coli. The RNaseA-CO gene
was PCR-amplified with terminal primers NDEIRACOF (5′-CACACACATATGAAAGA AACCGCGGCGGCCAAA-3′) and
RACOHINDR (5′-CACACAAAGCTTTTATTACACGCTCGCATCAAAATGCAC-3′) to remove the pELB leader sequence
and to introduce the 5′ and 3′ restriction sites NdeI and HindIII, respectively. The recombinant gene was
subsequently digested with NdeI and HindIII, subcloned into the NdeI- and HindIII-digested pET22b(+) expression
vector (EMD Chemicals, San Diego, CA), and transformed into E. coli XL10-Gold cells (Stratagene, La Jolla, CA).
This pET22b(+)-RNaseA-CO construct served as a template for all subsequent DNA substitutions. The T17A and
T82A mutations were introduced by the QuikChange Site-Directed Mutagenesis Kit (Stratagene) using
RACOT17AF/RACOT17AR (5′-CAGCACATGGATAGCAGCGCGAGCGCGGCGAGCAGCAGC-3′/5′GCTGCTGCTCGCCGCGCTCGCGCTGCTATCCATGTGCTG-3′) and RACOT82AF/RACOT82AR (5′GCTATAGCACCATGAGC ATTGCGGATTGTCG CGAAACCGGCAGC-3′/5′GCTGCCGGTTTCGCGACAATCCGCAATGCTCATGGTGCTATAGC-3′) primer pairs, respectively.

Protein Expression, Refolding, and Purification

To reduce toxicity effects caused by the overexpression of RNase A, expression of mutants T17A and T82A was
performed in E. coli C41(DE3) cells (Lucigen, Middleton, WI). Isotopically 15N-labeled RNase A mutants T17A and
T82A were expressed, refolded, and purified according to a previously optimized protocol (19).

Solution NMR Experiments
All NMR experiments were performed at 298 K as calibrated with a standard methanol sample (21) on Varian
NMR spectrometers equipped with triple-resonance probes and pulsed-field gradients. A 773 μM 15N-labeled
sample of RNase A-T17A and an 830 μM 15N-labeled sample of RNase A-T82A were used to perform all the
relaxation experiments and the 3′-CMP titration experiments. Relaxation-compensated
Carr−Purcell−Meiboom−Gill (rcCPMG) experiments (15) were performed as described previously (19) on ligandfree enzymes at magnetic fields of 11.7, 14.1, and/or 18.8 T. Resonance assignments for mutant enzymes were
initially based on comparison with wild-type chemical shifts and verified with a 1H−15N TOCSY-HSQC experiment
(22).
CPMG dispersion data for WT were fit as described previously (23). For CPMG data with T17A, all residues were
in the fast-exchange regime and so were analyzed using the fast-limit equation as described previously (24). ϕex
(pApBΔω2), in which pA and pB are the equilibrium site populations for conformations A and B, respectively, and
Δω is the chemical shift difference for an individual nucleus between conformations A and B, was determined.

For residues in the fast limit of conformational exchange, ϕex is determined directly from the fits, whereas for
residues in intermediate to slow exchange, ϕex is obtained directly from the product of the individual values.

3′-CMP Titration Experiments
The kinetics of the binding interaction of 3′-CMP with RNase A mutants T17A and T82A were measured by
titration of 3′-CMP as previously published (19, 23, 25), where 15N HSQC spectra were recorded for titration
points corresponding to 3′-CMP:enzyme molar ratios of 0, 0.174, 0.393, 0.691, 1.31, 2.71, 6, and 12. These twodimensional experiments were conducted with 256 t1 and 8192 t2 points with proton and nitrogen spectral
widths of 1600 and 7000 Hz, respectively. NMR line shape analysis was performed using BiophysicLab developed
in the Kovrigin laboratory at the Medical College of Wisconsin (http://biophysicslab.net/). In brief, the onedimensional spectral slices from the NMR two-dimensional HSQC series from titrations were exported using the
BiophysicsLab extension for Sparky spectral processing software (http://www.cgl.ucsf.edu/home/sparky/).
Fitting of a series of one-dimensional slices for each individual residue was performed using BiophysicsLab in the
following steps: (1) normalization of the peak area to remove broadening in the orthogonal dimension, (2) fitting
of the initial and final traces to Lorentzian line shapes to determine an initial guess for peak positions and line
widths, and (3) fitting of the full titration series with the Bloch−McConnell equations [describing exchange
between free and ligand-bound states of the protein (25, 26)] to determine the ligand dissociation rate constant
(koff), the equilibrium dissociation constant (Kd), and the frequency and line width of the bound state.
Detemination of 95% confidence intervals for the fitting parameters was performed utilizing the Monte Carlo
approach. A common correction to the molar ratio of the ligand to the protein in the NMR sample was also
optimized to account for the limited accuracy of the protein concentration as well as the small uncertainty in the
ligand absorption coefficient. After every individual peak had been fit, the global fitting session was performed
where all data sets for a specific form of RNase A (WT, T17A, or T82A) were fit to common values of koff, Kd, and
the correction to ligand:protein molar ratio, while optimizing individual frequencies and line widths of the bound
complex for every peak. A small residual deviation of the fitted curves from experimental data was noted, which
possibly originates from NMR instrument drift during the titration series. However, peak positions and widths
were reproduced reasonably well, making it possible to perform a quantitative comparison between RNase A
variants.

Results and Discussion
Chemical Shift Assignments
The 1H−15N chemical shifts of both mutants are similar to those of WT (Figure 1). This similarity along with
results from the TOCSY-HSQC analysis allowed assignment of 97 and 96% of assigned WT residues for T17A and
T82A, respectively. Unassigned residues in each mutant that are assigned in WT are Asn44 and Gln103 for T17A
and Thr17, Asn44, and Asn103 for T82A. In addition, Ala17 and Ala82 are unassigned in each mutant enzyme.
Unassigned WT residues Glu2, Ala20, and Ser21 are well-resolved in both T17A and T82A. In T17A, Thr82 is
assigned, whereas in T82A, Thr17 is not assigned. The lack of an assignment for Thr17 in the T82A mutant may
be a result of the larger effects caused by mutation of Thr82 relative to Thr17 (vide infra). The average chemical
shift differences between T17A and WT and between T82A and WT are 0.04 ± 0.06 ppm (n = 106) and 0.06 ±
0.09 ppm (n = 105), respectively. The sites of chemical shift differences from the WT enzyme are shown as a
function of residue in Figure 1C,D and mapped onto the structure in Figure 1E,F. These data indicate that both
mutants fold properly and are structurally very similar to the WT enzyme.

Figure 1. Chemical shift variations caused by the T17A and T82A mutations in RNase A. (A) Overlay of 15N HSQC
spectra for WT (blue) and RNase A-T17A (red). (B) Overlay of 15N HSQC spectra for WT (blue) and RNase A-T82A
(red). (C and D) Composite chemical shift differences for WT vs T17A (C) and WT vs T82A (D) shown as a function
of amino acid sequence. (E and F) Mapping of Δδ for WT vs T17A (E) and WT vs T82A (F) on the threedimensional structure of RNase A (Protein Data Bank entry 1RPF). Residues with Δδ values of >0.1 ppm are
represented as red spheres; the site of mutation is shown as a white sphere, and 3′-CMP is shown in ball-andstick representation. Chemical shift variations are a composite of amide 1H and 15N chemical shift values
calculated according to the relationship Δδ = [(δHN2 + δN2/25)/2]1/2, in which Δδ is the difference in chemical shift
between the two proteins for amide 1HN and 15NH nuclei (33). 15N HSQC spectra were recorded at 14.1 T, 298 K,
and pH 6.4.

Differential Interaction with a Ligand

To assess the similarities to WT with respect to ligand binding, we analyzed the chemical shift changes for WT,
T17A, and T82A upon binding the product analogue 3′-CMP. For most residues in both mutant enzymes, the
magnitude and direction of the 15N chemical shift changes upon 3′-CMP binding are similar to those observed for
WT (Figure 2), suggesting that both mutant enzymes experience electrostatic and conformational changes
similar to those of the WT enzyme when it encounters 3′-CMP. However, for T17A and T82A, there are several
residues that display significant differences in their response to 3′-CMP binding (Figure 2). These differences
from WT are more pronounced for the T82A mutant than for the T17A enzyme, indicating that mutation of
Thr82 is a more disruptive one with respect to ligand binding than the Thr17 mutation. Alterations in loop 1
upon interaction with 3′-CMP are evident in both mutants. Furthermore, Asp83 and Cys84, near the Thr82 site,
and Gln69 also display differences with respect to WT behavior. However, in the T82A enzyme, additional
differences are also observed between β4 residues 43−53 and Phe120 and Asp121 (Figure 2), in which these
latter two residues are located at the catalytic site and residues in β4 form the B2 subsite. Thus, the T82A
mutation additionally alters how the residues around His48 respond to binding of 3′-CMP, an effect that also
appears to propagate to longer distances, reaching Phe120 and Asp121, which are 12 Å distant but contact the
phosphate group of the 3′-CMP ligand. This effect of altered product-induced chemical shift changes was also
observed in the H48A and loop 1 chimera enzymes studied previously (18, 19). Thus, it appears that alanine at
position 82 alters the ability of RNase A to undergo ligand-induced changes as does complete removal of His48
(18).

Figure 2. Effects of mutations on product analogue binding. The alteration in the response of RNase A to binding
3′-CMP is shown for (A and C) T17A and (B and D) T82A. In panels A and B, the chemical shift difference between
the apoenzyme and the 3′-CMP-bound enzyme is shown as a function of amino acid residue, in which ΔΔ =
(δWTapo − δWTCMP) − (δmutantapo − δmutantCMP), where δ is the residue specific 15N chemical shift in the presence and
absence of 3′-CMP for WT and mutant RNase A enzymes. ΔΔ then represents the deviation of the mutant's
interaction with CMP compared to that of WT. In panels C and D, ΔΔ values of greater than ±0.2 ppm are shown
on the RNase A structure as red spheres; unassigned or overlapped residues are colored black.
NMR line shape analysis of a 3′-CMP titration series with all three enzymes was performed to further investigate
the kinetics of interaction of the 3′-CMP product analogue with RNase A. For WT, the value for the dissociation
rate constant (koff) that we obtain from line shape analysis is 2200 ± 60 s−1 and is in agreement with previously
determined values (19, 25). For T82A, koff equals 2200 ± 300 s−1 and is identical to the WT value, whereas for
T17A, the value of koff is slightly higher (3100 ± 300 s−1) (Figure 3). For RNase A, the product release step is ratelimiting for the overall enzymatic reaction (3). The line shape data here suggest that mutation of Thr82 has no
effect on this rate constant whereas mutation of Thr17 results in a slight elevation of the product analogue
dissociation rate constant. Despite the similarities in the koff values with that of WT, the mutants bind 3′-CMP
between 7- and 10-fold weaker than WT. Thus, these mutations primarily elicit their effects via decreases in kon
(Table 1), perhaps because of their disruption of the active site structure and dynamics. For T82A, these data
suggest that ms protein motions are uncoupled from product dissociation, unlike the case with WT in which
motion and product release are concerted.

Figure 3. NMR line shape analysis of 3′-CMP binding. The titration curves of residue K41 are shown for WT, T17A,
and T82A for 3′-CMP:enzyme molar ratios of 0 (black), 0.174 (red), 0.393 (green), 0.691 (blue), 1.31 (cyan), 2.71
(purple), 6 (pink, in only T17A and T82A), and 12 (gray). Best-fit curves obtained with BiophysicsLab (—) are
superimposed on the experimental data (---).
Table 1. Interaction of 3′-CMP with WT, RNase A-T17A, and RNase A-T82A
enzyme
Kd (μM) koff (s−1)
kon (×108 M−1 s−1)
WT
14 ± 4a
2200 ± 100 1.57 ± 0.45
RNase A-T17A 100 ± 20 3100 ± 260 0.31 ± 0.07
RNase A-T82A 120 ± 25 2200 ± 260 0.18 ± 0.04
a
Uncertainties determined from a Monte Carlo estimation.

Conformational Exchange Motions

We previously investigated the 15N backbone dynamics and functional effects of various mutations in RNase A
and found that residues experiencing conformational exchange motions can be grouped into two separate
clusters showing distinct dynamical features and distinct sensitivity to solvent 2H content as summarized in
Figure 4 (18). Millisecond motions in cluster 1 are sensitive to the deuterium content of the solvent and
encompass several residues in the α2, β1, β2, β4, and loop 1 regions. In contrast, cluster 2 consists of residues of
loop 4 and β2, and the observed millisecond motions in this region are insensitive to 2H solvent isotope. These
two clusters of residues are separated by the active site cleft and form two structurally distinct regions of the
protein (Figure 4). In addition, the chemical exchange behavior of each cluster appears to be independently

affected by mutation. For example, replacement of cluster 2 residue Asp121 with alanine affects the dynamic
behavior of all of cluster 2 but does not influence the conformational exchange of cluster 1 residues (25).
Conversely, replacements of Thr82 (this study), His48 (18), and loop 1 (19), all of which are located in cluster 1,
almost completely abolish conformational exchange motions for residues of cluster 1 yet cause insignificant
changes to the millisecond motions of cluster 2 (Figure 4).

Figure 4. Effect of mutation on microsecond to millisecond dynamics in RNase A. Residues with 15N CPMG
dispersion profiles are depicted as blue spheres. Residues with no chemical exchange relative to WT (i.e.,
residues that lost microsecond to millisecond dynamics upon mutation) are depicted as red spheres. Unassigned
residues are depicted as gray spheres. Secondary structure elements and clusters discussed in the text are
highlighted on the structure of WT (Protein Data Bank entry 1RPF). The site of mutation is colored cyan, and 3′CMP is shown as yellow sticks.
Interestingly, despite being nearly 20 Å from the active site, His48 was found to be a key modulator in coupling
protein motion with enzyme function, a result that was attributed to the involvement of the side chain imidazole
of His48 (Figure 4 and Scheme 1) (18). It was postulated that protonation and/or deprotonation of this imidazole
side chain would act as a switch to facilitate the open-to-closed conformation of the enzyme by connecting
motions, which occur on the time scale of catalytic turnover, from loop 1 to β1, β2, and β4 through His48.
Replacement of His48 with alanine completely abolishes conformational exchange in RNase A, as does replacing
the entire loop 1 of RNase A (residues 14−25) with the shorter loop 1 of the human homologue ECP (Figure 4)
(19). To further evaluate the importance of the hydrogen bonding network involving His48 and its surrounding
local environment in the millisecond motions in RNase A, we investigated molecular motions on this time scale
by 15N CPMG relaxation NMR dispersion experiments (15) with WT, T17A, and T82A.
In a fashion similar to that for all other prior mutations in this region, replacement of Thr82 with alanine
eliminates the positive CPMG relaxation dispersion curves, which are the hallmark of microsecond to millisecond
motions for many residues of cluster 1. These results are similar to what is observed for the H48A and RNase
AECP enzymes (Figure 5A−C) (18), further confirming the importance of the hydrogen bonding interaction
between His48 and Thr82 in propagating motions throughout cluster 1 (27-31). The importance of this
interaction is underscored by the coevolution of these two residues in RNase A sequences, as noted above.

Further inspection indicates that the motions in loop 1 and for some surrounding residues are not abolished in
the T82A mutant but rather shifted to a different time scale compared to those in WT (Figure 6). In the T82A
enzyme, the transverse relaxation rates (R2 for τcp = 0.625 ms) are significantly elevated for several residues
compared to those of their WT and T17A counterparts. The elevated rates in T82A indicate the presence of
microsecond to millisecond motions that are not suppressed even at the fastest CPMG pulsing rates employed in
the relaxation dispersion experiment. The inability to suppress the effects of molecular motions on the observed
R2 value by a CPMG pulse train suggests the motions are occurring on a time scale faster than 3.2/τcp (32), where
τcp is the delay between CPMG 180° pulses. For these experimental conditions, this would indicate that
molecular motion is faster than approximately 5000 s−1. This value is compared to ∼2000 s−1, which is the
observed exchange rate constant for motions in WT (16). As one can see in Figure 6, these regions of elevated
transverse relaxation rates are localized to loop 1 and not the remainder of cluster 1. This suggests that
mutation of Thr82 not only accelerates motions in loop 1 but also uncouples loop 1 motions from the remainder
of the protein, effectively cutting off the flow of motion to the active site region. The latter effect evidently
reduces the affinity of the enzyme for 3′-CMP by decreasing kon; in other words, mutation of Thr82 uncouples
the loop 1 motions with residues in the enzyme active site.

Figure 5. Conserved short-range conformational dynamics in mutant T17A. 15N CPMG (14.1 T) dispersion curves
of residues (A) F46, (B) V47, and (C) T82 for WT (black circles), RNase A-T17A (red squares), RNase A-T82A
(orange triangles), RNase A-H48A (green diamonds) (18, 19), and RNase AECP (blue inverted triangles) (19). Insets
show close-ups of the RNase A-T17A data (same legend and axis labels).

Figure 6. Effects of mutations on transverse relaxation rates (R2). (A) Residue specific transverse relaxation rates
(R2,avg) equal 0.5(R2in-phase + R2anti-phase), where R2,avg is the average of 15N in-phase and antiphase transverse
relaxation rates for WT (black), T17A (red), and T82A (blue). R2 values were determined using a 40 ms constant
relaxation time version of the relaxation-compensated CPMG experiment in which the delay between CPMG
180° refocusing pulses was set to 0.625 ms. (B) Residues in T82A with significantly elevated R2 values are shown
as red spheres mapped onto the structure of RNase A, with black regions corresponding to overlapped or
unassigned residues. Experiments were performed at 14.1 T, 298 K, and pH 6.4.
In contrast to T82A, the mutation at position 17 does not significantly alter the R2 values at τcp = 0.625 ms from
their WT values (Figure 6), suggesting a similar time scale of motions in T17A and WT. Moreover, the dispersion
curves for T17A are similar to that of WT, though with some interesting differences. The replacement of Thr17
with alanine has a significant effect on the dynamics of cluster 1 residues. Conformational exchange for residues
Ala5, Gln11, Ser15, Ser18, Ser22, Met30, Ser32, Asn34, Leu35, Phe46, and Val47 remains with a kex of 3200 ± 350
s−1, based on a global analysis of CPMG data at 600 and 800 MHz. The exchange rate constant for motions in
T17A is 1.6-fold higher than it is in WT. This measured value of kex is similar to the koff value for 3′-CMP measured
from the line shape analysis indicating that motions around His48 and loop 1 remain coupled to the active site
motions that participate in product release unlike what is observed in the T82A mutant. The role of Thr17 in this
regard appears to be to maintain a reduced product dissociation rate by maintaining slower protein motions.
The functional reason, if any, for preserving slower motions is unclear.
Overall, these results are consistent with the linear proton inventory experiments probed by NMR relaxation
dispersion methods that suggested a single dominant proton was important in these motions. On the basis of
the results of this work, removal of the interaction between Thr82 and His48 has a large effect on protein
motions, whereas removing the His48−Thr17 interaction has an only modest effect. The only interaction with
the Nε2 position of His48 occurs via Thr82. In contrast, the T17A mutation retains two of three interactions with
Nδ1 on the other side of the His48 imidazole ring (Scheme 1). Thus, mutation of Thr17 does not completely sever

the connection of His48 with loop 1, but elimination of Thr82 cannot be overcome by other existing interactions.
Nonetheless, the importance of Thr17 in RNase A motions should not be underestimated.
A comparison of ϕex values for identical residues in WT and T17A gives a slope of 0.38, indicating that the
amplitude of the motional effect is dampened in T17A (Figure 7). However, this slope is dominated by the data
of Phe46 and Val47, and as seen in the inset of Figure 7, there are as many data points for which ϕexT17A > ϕexWT
as there are for which ϕexT17A < ϕexWT, indicating a nonuniform effect of mutation on the motional parameters,
despite a correlation coefficient of 0.92 for these data. ϕex in these plots equals the papbΔω2 product that arises
from the conformational exchange motion and its effect on the measured R2. At present, it is not possible to
know whether mutation of Thr17 causes a change in the equilibrium populations, Δω, or both. Whatever the
mechanistic origins of the altered motions, it is not equally manifest in individual amino acid residues, yet the
kinetics of the conformational motion for all these residues in T17A are the same.

Figure 7. Comparison of dispersion parameters for WT and T17A. The correlation of ϕex for WT and T17A for
eight common residues is shown using the one-letter identification code for each. The inset is an expansion of
the region in which ϕex < 10000 s−2. The line represents a best-fit linear regression to all the data points.
These studies illuminate how tightly controlled and finely tuned millisecond motions are in enzymes. Removal of
a single, and lone, interaction between His48 and Thr82 abolishes millisecond motions in cluster 1 and shifts
them toward the low microsecond regime. Deletion of the interaction between Thr17 and His48, which amounts
to removal of one of the three total H-bonding interactions, slightly shifts the kex to a higher value for residues in
cluster 1. In both cases, motions in cluster 2 are unaffected. Despite the sensitivity of the region surrounding
His48 to perturbations, these studies do suggest that it may be possible to very selectively alter conformational
dynamics and ligand binding for the purposes of rational protein design.
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